TD Cowen Remains a Hold on Pfizer (PFE)
Stay Ahead of the Market:
Discover outperforming stocks and invest smarter with Top Smart Score Stocks.
Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener.
Scala covers the Healthcare sector, focusing on stocks such as Merck & Company, Pfizer, and AstraZeneca. According to TipRanks, Scala has an average return of 4.2% and a 55.62% success rate on recommended stocks.
In addition to TD Cowen, Pfizer also received a Hold from Citi's Geoff Meacham in a report issued today. However, yesterday, Jefferies maintained a Buy rating on Pfizer (NYSE: PFE).
Based on Pfizer's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $17.76 billion and a net profit of $410 million. In comparison, last year the company earned a revenue of $14.25 billion and had a GAAP net loss of $3.34 billion
Based on the recent corporate insider activity of 27 insiders, corporate insider sentiment is neutral on the stock. Last month, JENNIFER B. DAMICO, the SVP & Controller of PFE sold 3,249.00 shares for a total of $84,373.90.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
29 minutes ago
- Globe and Mail
Law Offices of Frank R. Cruz Encourages SelectQuote, Inc. (SLQT) Investors To Inquire About Securities Fraud Class Action
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased SelectQuote, Inc. ('SelectQuote' or the 'Company') (NYSE: SLQT) securities between September 9, 2020 and May 1, 2025, inclusive (the 'Class Period'). SelectQuote investors have until October 10, 2025 to file a lead plaintiff motion. IF YOU SUFFERED A LOSS ON YOUR SELECTQUOTE, INC. (SLQT) INVESTMENTS, CLICK HERE TO SUBMIT A CLAIM TO POTENTIALLY RECOVER YOUR LOSSES IN THE ONGOING SECURITIES FRAUD LAWSUIT. You can also contact the Law Offices of Frank R. Cruz to discuss your legal rights by email at info@ by telephone at (310) 914-5007, or visit our website at What Happened? On May 1, 2025, the U.S. Department of Justice ('DOJ') filed a False Claims Act complaint against SelectQuote, alleging, '[f]rom 2016 through at least 2021' SelectQuote received 'tens of millions of dollars' in 'illegal kickbacks' from health insurance companies in exchange for steering Medicare beneficiaries to enroll in the insurers' plans. Further, SelectQuote, in exchange for kickbacks, engaged in a conspiracy with major insurers to illegally discriminate against beneficiaries deemed to be less profitable, including those with disabilities. The DOJ concluded that SelectQuote made materially false claims by stating it offers 'unbiased coverage comparisons' when in fact it 'repeatedly directed Medicare beneficiaries to the plans offered by insurers that paid them the most money, regardless of the quality or suitability of the insurers' plans.' On this news, SelectQuote's stock price fell $0.61, or 19.2%, to close at $2.56 per share on May 1, 2025, on unusually heavy trading volume. What Is The Lawsuit About? The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that the Company was directing Medicare beneficiaries to the plans offered by insurers that best compensated SelectQuote, regardless of the quality or suitability of the insurers' plans; (2) that SelectQuote did not provided unbiased comparison shopping for Medicare Advantage insurance plans; (3) that SelectQuote received illegal kickbacks to steer Medicare beneficiaries to certain insurers and limit enrollment in competitors' plans; (4) that as a result, SelectQuote had not complied with applicable laws, regulations, and contractual provisions; (5) that SelectQuote was vulnerable to regulatory and legal sanctions as a result of its conduct, including claims that it had violated the False Claims Act; and (6) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. Contact Us To Participate or Learn More: If you purchased SelectQuote securities, wish to learn more about this action, or have any questions concerning this announcement or your rights or interests with respect to these matters, please click HERE or contact us at: This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Globe and Mail
29 minutes ago
- Globe and Mail
Rosen Law Firm Urges CTO Realty Growth, Inc. (NYSE: CTO, CTO-PA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, announces that shareholders filed a class action lawsuit on behalf of purchasers and acquirers of CTO Realty Growth, Inc. (NYSE: CTO, CTO-PA) securities between February 18, 2021 and June 24, 2025, both dates inclusive (the 'Class Period'). CTO Realty Growth is a real estate investment trust ('REIT'). For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that CTO Realty Growth, Inc. (NYSE: CTO, CTO-PA) Misled Investors Regarding its Business Operations. According to the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) CTO's dividends were less sustainable than defendants had led investors to believe; (2) CTO Realty Growth used deceptive and unsustainable practices to artificially inflate its Adjusted Funds from Operations ('AFFO') and overstate the true profitability of its Ashford Lane property; (3) accordingly, CTO Realty Growth's business and/or financial prospects were overstated; and (4) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. What Now: You may be eligible to participate in the class action against CTO Realty Growth, Inc. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by October 7, 2025. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here. All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Rosen Law Firm: Some law firms issuing releases about this matter do not actually litigate securities class actions. Rosen Law Firm does. Rosen Law Firm is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses, improving corporate governance structures, and holding company executives accountable for their wrongdoing. Since its inception, Rosen Law Firm has obtained over $1 billion for shareholders.
Globe and Mail
an hour ago
- Globe and Mail
Photronics to Participate in Upcoming Investor Events
BROOKFIELD, Conn., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Photronics, Inc. (Nasdaq:PLAB), a worldwide leader in photomask technologies and solutions, today announced its participation in the following upcoming investor conferences: Date: Wednesday, August 13 th Event: Oppenheimer's 28 th Annual Technology, Internet, & Communications Conference Location: Virtual Date: Thursday, September 4 th Event: TD Cowen's 53 rd Technology Growth Cap Summit Location: New York, NY Date: Wednesday, September 10 th Event: Singular Research Investor Conference Location: New York, NY Institutional investors interested in participating in these events should contact their representative at these firms. About Photronics Photronics is a leading worldwide manufacturer of integrated circuit (IC) and flat panel display (FPD) photomasks. High precision quartz plates that contain microscopic images of electronic circuits, photomasks are a key element in the IC and FPD manufacturing process. Founded in 1969, Photronics has been a trusted photomask supplier for over 56 years. The company operates 11 strategically located manufacturing facilities in Asia, Europe, and North America. Additional information on the company can be accessed at
